Seeking Alpha

Quidel (QDEL) and Life Technologies (LIFE) receive the FDA's 510(k) clearance to market their...

Quidel (QDEL) and Life Technologies (LIFE) receive the FDA's 510(k) clearance to market their products together for diagnosing Clostridium difficile bacterial infections (CDI), which have been linked to 14,000 deaths a year in the U.S. The Quidel product involved is its Molecular Direct C. difficile Assay and those of Life are its Real-Time PCR Instruments for monitoring hospital-acquired infections . (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector